Kihara James sold ACAD
May 26, 2026 · Form 4 insider transaction
Kihara James sold 5,401 shares of ACADIA Pharmaceuticals Inc. at $21.18 per share, a transaction worth $114.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.1801 to $21.185, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.; Includes 781 shares of the Issuer's common stock acquired by the reporting person on May 15, 2026 pursuant to an employee stock purchase plan.